AzTrials
AzTrials

StrokeAUTOTABNCT01565044

Automatic Versus Intentional Movement Exercises to Enhance Arm Functions After Stroke

A study testing motor training in people with Stroke and Upper-limb Paresis, run by Hospices Civils de Lyon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many patients retain upper-limb motor impairment following stroke. Most conventional rehabilitation techniques are aimed to improve motor intentional movement by repeated exercises. These techniques require attentional load and are responsible for significant fatigue that probably represents a limiting factor. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Stroke, Upper-limb Paresis
What is being tested?
motor training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
26 participants
Where
1 siteFrance
Study dates
27 Sep 2012to 3 Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All subjects must be between the ages of 18-80 and must not be pregnant
  • Patients volunteer to participate in the study, with a written informed consent signed
  • Affiliation to a national health insurance program
  • Hemiplegia after stroke
  • Stroke onset >6 weeks and <4 years prior to study enrollment
  • Patients able to perform the exercises on the automated table

Who cannot join

  • Pregnancy
  • Excessive pain in any joint of the paretic extremity (VAS>5)
  • Coexistent major neurological or psychiatric disease as to decrease number of confounders
  • Subjects with global aphasia and deficits of comprehension
  • Any substantial decrease in alertness, language reception, or attention that might interfere with understanding instructions for motor testing

Trial locations and contacts

1 site in 1 country.

France1 site
  • Service de Médecine Physique et de Réadaptation et Plateforme 'Mouvement et Handicap', Hôpital Henry Gabrielle, HCL

    Saint-Genis-Laval, 69235

Other trials in France

About this study

Many patients retain upper-limb motor impairment following stroke. Most conventional rehabilitation techniques are aimed to improve motor intentional movement by repeated exercises. These techniques require attentional load and are responsible for significant fatigue that probably represents a limiting factor. Alternatively, the automatic control of action is now well documented. A rehabilitation method based on this principle could allow recovery of more natural movements.

Hypothesis: Stimulating automatic motricity improves upper-limb motor skills compared with a rehabilitation technique based on intentional movements.

Being tested
motor training
Keywords
Stroke, hemiplegia, automatic pilot, upper-limb rehabilitation
Medical subject headings
Stroke, Paresis, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • motor trainingOther

    Subject will perform prehension exercises on an automated table. After the initiation of the arm movement, the target to be grasped is programmed to move in order to stimulate automatic motricity.

  • motor trainingOther

    Subject will perform prehension exercises on an automated table. After the initiation of the arm movement, the target to be grasped will remain static in order to involve intentional motricity.

Study groups in NCT01565044
Study groupRoleWhat they receive
" AUTO " GroupExperimentalNot described
Receives: Other: motor training
" CONTROL " GroupSham comparatorNot described
Receives: Other: motor training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl Meyer assessment (upper extremity) of motor recovery following stroke

    we are looking for a change in scores between the baseline session score (Day 1), and those collected during this follow-up session (Day 26).

    Measured: 2 weeks following the last day of the intervention (Day 26)

Secondary outcomes (7)
  1. Fugl Meyer assessment (upper extremity) of motor recovery following stroke

    we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session

    Measured: immediately following the last day of the intervention (Day 12)

  2. modified Ashworth scale

    we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session.

    Measured: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)

  3. Visual Analog Pain Scale

    we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session.

    Measured: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)

  4. Box and block test

    we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session

    Measured: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)

  5. Frenchey Arm Test

    we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session.

    Measured: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)

  6. Motor Activity Log (MAL

    we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session.

    Measured: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)

  7. Functional independence scale (MIF)

    we are looking for a change in scores between the baseline session score (Day 1), and those collected during each follow-up session

    Measured: immediately following the last day of the intervention (Day 12) and 2 weeks following the last day of the intervention (Day 26)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2012 (estimated)
  2. Study start27 Sep 2012
  3. Primary completion3 Nov 2017
  4. Study completion3 Nov 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
26 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01565044
Sponsor's protocol ID
2011.675
Acronym
AUTOTAB
Status last verified
Dec 2025
First submitted
26 Mar 2012
Last updated
19 Dec 2025
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing motor training in people with Stroke and Upper-limb Paresis, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl Meyer assessment (upper extremity) of motor recovery following stroke (time frame: 2 weeks following the last day of the intervention (Day 26)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
AUTOTAB Clinical Trial NCT01565044 | AzTrials